Cargando…

Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis

Apolipoprotein (Apo)-based mimetic peptides have been shown to reduce atherosclerosis. Most of the ApoC-II and ApoE mimetics exert anti-atherosclerotic effects by improving lipid profile. ApoC-II mimetics reverse hypertriglyceridemia and ApoE-based peptides such as Ac-hE18A-NH2 reduce cholesterol an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benitez Amaro, Aleyda, Solanelles Curco, Angels, Garcia, Eduardo, Julve, Josep, Rives, Jose, Benitez, Sonia, Llorente Cortes, Vicenta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396846/ https://www.ncbi.nlm.nih.gov/pubmed/34441867 http://dx.doi.org/10.3390/jcm10163571

Ejemplares similares

Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control
por: García, Eduardo, et al.
Publicado: (2023)

LRP1-Mediated AggLDL Endocytosis Promotes Cholesteryl Ester Accumulation and Impairs Insulin Response in HL-1 Cells
por: Actis Dato, Virginia, et al.
Publicado: (2020)

Relationship among LRP1 expression, Pyk2 phosphorylation and MMP‐9 activation in left ventricular remodelling after myocardial infarction
por: Revuelta‐López, Elena, et al.
Publicado: (2017)

Inhibitory Effects of LRP1-Based Immunotherapy on Cardiac Extracellular Matrix Biophysical Alterations Induced by Hypercholesterolemia
por: Samouillan, Valerie, et al.
Publicado: (2023)

Immunization with the Gly(1127)-Cys(1140) amino acid sequence of the LRP1 receptor reduces atherosclerosis in rabbits. Molecular, immunohistochemical and nuclear imaging studies
por: Bornachea, Olga, et al.
Publicado: (2020)

Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells
por: Benitez-Amaro, Aleyda, et al.
Publicado: (2022)

Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis
por: Griñán, Raquel, et al.
Publicado: (2022)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
por: Rivas-Urbina, Andrea, et al.
Publicado: (2020)

Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by (18)F-FDG PET in patients with a recent ischemic stroke
por: Garcia, Eduardo, et al.
Publicado: (2023)

The apolipoprotein receptor LRP3 compromises APP levels
por: Cuchillo-Ibañez, Inmaculada, et al.
Publicado: (2021)

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Méndez-Lara, Karen Alejandra, et al.
Publicado: (2020)

Biophysical and Lipidomic Biomarkers of Cardiac Remodeling Post-Myocardial Infarction in Humans
por: Samouillan, Valerie, et al.
Publicado: (2020)

Soluble LRP1 is an independent biomarker of epicardial fat volume in patients with type 1 diabetes mellitus
por: de Gonzalo-Calvo, David, et al.
Publicado: (2018)

Publisher Correction: Soluble LRP1 is an independent biomarker of epicardial fat volume in patients with type 1 diabetes mellitus
por: de Gonzalo-Calvo, David, et al.
Publicado: (2019)

Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy
por: Roura, Santiago, et al.
Publicado: (2017)

Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
por: Getz, Godfrey S, et al.
Publicado: (2011)

Identification of new biophysical markers for pathological ventricular remodelling in tachycardia‐induced dilated cardiomyopathy
por: Benitez‐Amaro, Aleyda, et al.
Publicado: (2018)

Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake
por: Cedó, Lídia, et al.
Publicado: (2017)

Association with inflammatory cells and apolipoproteins to the progression of atherosclerosis
por: Eo, Hyun-Seon, et al.
Publicado: (2011)

LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis
por: Xian, Xunde, et al.
Publicado: (2017)

Human Apolipoprotein A-I-Derived Amyloid: Its Association with Atherosclerosis
por: Ramella, Nahuel A., et al.
Publicado: (2011)

Effect of Apolipoprotein E ε4 Allele on the Progression of Carotid Atherosclerosis Through Apolipoprotein Levels
por: Ma, Wenbing, et al.
Publicado: (2022)

The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice
por: Ma, Juan, et al.
Publicado: (2022)

Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis
por: Puig, Núria, et al.
Publicado: (2023)

TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice
por: Watt, Victoria, et al.
Publicado: (2011)

Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs
por: Fang, Bin, et al.
Publicado: (2018)

Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2010)

Low Density Lipoproteins Promote Unstable Calcium Handling Accompanied by Reduced SERCA2 and Connexin-40 Expression in Cardiomyocytes
por: Barriga, Montserrat, et al.
Publicado: (2013)

LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence
por: Ren, Qian, et al.
Publicado: (2021)

Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
por: Woo, Jennifer MP, et al.
Publicado: (2010)

An Apolipoprotein A-I Mimetic Peptide Designed with a Reductionist Approach Stimulates Reverse Cholesterol Transport and Reduces Atherosclerosis in Mice
por: Ditiatkovski, Michael, et al.
Publicado: (2013)

Expressão de Proteína-1 Relacionada a Receptor de Lipoproteína de Baixa Densidade (LRP1) em Monócito em Correlação com EIMC em Pacientes Mexicanos Hipertensos
por: Gamboa, Ricardo, et al.
Publicado: (2021)

Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility
por: Li, Jing, et al.
Publicado: (2011)

Simvastatin and Losartan Differentially and Synergistically Inhibit Atherosclerosis in Apolipoprotein E(-/-) Mice
por: Lee, Bok-Soo, et al.
Publicado: (2012)

Apolipoprotein D in Lipid Metabolism and Its Functional Implication in Atherosclerosis and Aging
por: Perdomo, German, et al.
Publicado: (2008)

IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice
por: Mantani, Polyxeni T., et al.
Publicado: (2015)

Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E(−/−) Mice
por: Rinne, Petteri, et al.
Publicado: (2018)

The Influence of Trehalose on Atherosclerosis and Hepatic Steatosis in Apolipoprotein E Knockout Mice
por: Stachowicz, Aneta, et al.
Publicado: (2019)

Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?
por: de Gonzalo-Calvo, David, et al.
Publicado: (2019)

Dissecting Molecular Differences between Wnt Coreceptors LRP5 and LRP6
por: MacDonald, Bryan T., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ipiindji8psullo77nvjve47rf